Ubimaior 50 mg - coenzyme q10 deficiency 14 capsules

Product Description

Drug used for the treatment of congenital coenzyme Q10 deficiency.

Therapeutic indications

Ubimaior 50 mg is used in the treatment of congenital coenzyme Q10 deficiency.

Active ingredients

One capsule contains:

Active ingredient
Ubidecarenone 50 mg

Excipients
Capsules: lactose, insoluble polyvinylpyrrolidone, polyvinylpyrrolidone, talc, colloidal hydrated silica, sodium lauryl sulfate, magnesium stearate, erythrosine E 127, iron oxide E 172, titanium dioxide E 171, gelatin.

Dosage

The capsules of Ubimaior 50 mg should be administered in one dose per day, unless otherwise prescribed by your doctor.

Contraindications

Individual hypersensitivity already known to the preparation.

Interactions

None known.

Side effects

UBIMAIOR is generally well tolerated. Gastric disturbances, reduced appetite, nausea, diarrhea, and skin rashes have occasionally been reported during treatment. If these side effects occur, discontinue treatment and consult your doctor.

Overdose

No cases of overdose have been described in the literature.

Pregnancy and breastfeeding

Even though teratological studies conducted with UBIMAIOR on animals have not shown any teratogenic effect, however, as with other drugs, its administration during the first three months of pregnancy should only be carried out in case of real need under the direct supervision of a doctor.

Warnings

Keep the medicine out of the reach and sight of children.

Storage

Keep the medicine in the original container to protect it from light.

Format

14 hard capsules